View Author
study disease association heart rate variability genotype heart factor polymorphism lesion carotid atherosclerosi risk factors effect haplotype activity hypertension schmidt carotid atherosclerosis stroke promoter subject population progression fibrinogen blood angiotensinogen result marcd paraoxonase matter variability brain frequency analysis chapter participant allele patient vessel baseline group exacerbation level individual model table tiotropium pressure position follow-up b haplotype difference matter lesions cholesterol austrian schmidt h schmidt r university salmeterol blood pressure abnormality variant change angiotensinogen gene carotid arteries fazekas f prevention presence expression fazeka sequence health j clin heart disease women b-haplotype damage artery finding vessel disease
5 Most Recent Publications
|
Tiotropium versus salmeterol for the prevention of exacerbations of COPD
(Article)
Vogelmeier, C. Hederer, B. Glaab, T. Schmidt, H. Rutten-van Mölken, M.P.M.H. Beeh, K-M. Rabe, K.F. Fabbri, L.M. |
2011-03-24
|
|
Association of health behaviour with heart rate variability: A population-based study
(Article)
Kluttig, A. Schumann, B. Swenne, C.A. Kors, J.A. Kuss, O. Schmidt, H. Werdan, K. Haerting, J. Greiser, K.H. |
2010-11-25
|
|
Cardiovascular diseases, risk factors and short-term heart rate variability in an elderly general population: The CARLA study 2002-2006
(Article)
Greiser, K.H. Kluttig, A. Schumann, B. Swenne, C.A. Kors, J.A. Kuss, O. Haerting, J. Schmidt, H. Thiery, J.P. Werdan, K. |
2009-03-01
|
|
Genetic Determinants of Cerebral Small Vessel Disease
(Doctoral Thesis)
Schmidt, H. |
2005-09-14
|
|
Angiotensinogen gene promoter haplotype and microangiopathy-related cerebral damage: results of the Austrian Stroke Prevention Study
(Article)
Schmidt, H. Fazekas, F. Kostner, G.M. Schmidt, R. Duijn, C.M. van |
2001-01-01
|